Annual Shareholders Equity
$89.42 M
+$8.67 M+10.73%
31 December 2023
Summary:
Lyra Therapeutics annual stockholders equity is currently $89.42 million, with the most recent change of +$8.67 million (+10.73%) on 31 December 2023. During the last 3 years, it has risen by +$14.93 million (+20.04%). LYRA annual shareholders equity is now at all-time high.LYRA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$20.62 M
-$10.36 M-33.44%
30 September 2024
Summary:
Lyra Therapeutics quarterly stockholders equity is currently $20.62 million, with the most recent change of -$10.36 million (-33.44%) on 30 September 2024. Over the past year, it has dropped by -$63.62 million (-75.52%). LYRA quarterly shareholders equity is now -81.43% below its all-time high of $111.03 million, reached on 30 June 2022.LYRA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYRA Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.7% | -75.5% |
| 3 y3 years | +20.0% | -56.3% |
| 5 y5 years | +183.5% | - |
LYRA Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +160.6% | -81.4% | at low |
| 5 y | 5 years | at high | +172.5% | -81.4% | +116.3% |
| alltime | all time | at high | +172.5% | -81.4% | +116.3% |
Lyra Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $20.62 M(-33.4%) |
| June 2024 | - | $30.98 M(-60.0%) |
| Mar 2024 | - | $77.50 M(-13.3%) |
| Dec 2023 | $89.42 M(+10.7%) | $89.42 M(+6.2%) |
| Sept 2023 | - | $84.24 M(-14.5%) |
| June 2023 | - | $98.58 M(+49.2%) |
| Mar 2023 | - | $66.09 M(-18.2%) |
| Dec 2022 | $80.75 M | $80.75 M(-13.4%) |
| Sept 2022 | - | $93.22 M(-16.0%) |
| June 2022 | - | $111.03 M(+294.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $28.16 M(-18.0%) |
| Dec 2021 | $34.32 M(-53.9%) | $34.32 M(-27.3%) |
| Sept 2021 | - | $47.19 M(-17.9%) |
| June 2021 | - | $57.50 M(-14.9%) |
| Mar 2021 | - | $67.55 M(-9.3%) |
| Dec 2020 | $74.49 M(-160.4%) | $74.49 M(-7.9%) |
| Sept 2020 | - | $80.91 M(-6.8%) |
| June 2020 | - | $86.82 M(-168.5%) |
| Mar 2020 | - | -$126.78 M(+2.8%) |
| Dec 2019 | -$123.34 M(+15.2%) | -$123.34 M |
| Dec 2018 | -$107.07 M | - |
FAQ
- What is Lyra Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Lyra Therapeutics?
- What is Lyra Therapeutics annual shareholders equity year-on-year change?
- What is Lyra Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Lyra Therapeutics?
- What is Lyra Therapeutics quarterly shareholders equity year-on-year change?
What is Lyra Therapeutics annual stockholders equity?
The current annual shareholders equity of LYRA is $89.42 M
What is the all time high annual shareholders equity for Lyra Therapeutics?
Lyra Therapeutics all-time high annual stockholders equity is $89.42 M
What is Lyra Therapeutics annual shareholders equity year-on-year change?
Over the past year, LYRA annual stockholders equity has changed by +$8.67 M (+10.73%)
What is Lyra Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of LYRA is $20.62 M
What is the all time high quarterly shareholders equity for Lyra Therapeutics?
Lyra Therapeutics all-time high quarterly stockholders equity is $111.03 M
What is Lyra Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, LYRA quarterly stockholders equity has changed by -$63.62 M (-75.52%)